PCYN (PCYN) Stock Price & Analysis
PCYN (PCYN) rose 0.00% to USD 0.26 as of July 25, 2026 at 22:00 UTC, according to Nexqual real-time market data.
PCYN last closed at USD 0.26; the session ranged USD 0.26–0.26 on volume of 8,375 shares. Market capitalization is $2.12M, with a 52-week range of USD 0.1–0.28 (PNK). Source: Nexqual, July 25, 2026 at 22:00 UTC.
Key Statistics (as of July 25, 2026 at 22:00 UTC)
| Price | USD 0.26 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.26 |
| Open | USD 0.26 |
| Day Range | USD 0.26 – 0.26 |
| 52-Week Range | USD 0.1 – 0.28 |
| Volume | 8,375 shares |
| Market Cap | $2.12M |
| Exchange | PNK |
Technical Analysis (PCYN)
Nexqual's technical model rates PCYN "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 22:00 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 62.54 (neutral) |
| vs SMA50 | Above (USD 0.21) |
| MACD | 0.01 (positive) |
Analyst Ratings (PCYN)
Wall Street analysts rate PCYN "None", per Nexqual as of July 25, 2026 at 22:00 UTC.
| Consensus Rating | None |
|---|
Earnings (PCYN)
Source: Nexqual, July 25, 2026 at 22:00 UTC.
Financials & Fundamentals (PCYN)
| Total Revenue | $4.98M |
|---|---|
| Revenue Growth (YoY) | +17.50% |
| Gross Margin | +78.07% |
| Operating Margin | +0.63% |
| Profit Margin | -6.84% |
| ROE | -13.91% |
| Debt / Equity | 18.66 |
| Current Ratio | 3.08 |
| Total Cash | $908,820 |
| Total Debt | $426,718 |
| Free Cash Flow | $-49,208 |
Source: Nexqual, July 25, 2026 at 22:00 UTC.
Financial Health Score (PCYN)
Nexqual rates PCYN's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 22:00 UTC.
| Growth | Strong — Revenue +18% YoY (latest Q) |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $909K cash, no debt |
| Cash Flow | Weak — FCF negative: -$49K, burning cash |
| Efficiency | Critical — ROE -14%, ROA -4.3% |
Ownership (PCYN)
| Insider Ownership | +64.47% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 8.14M |
| Float | 4.29M |
Source: Nexqual, July 25, 2026 at 22:00 UTC.
Leadership (PCYN)
PCYN is led by Justice W. Anderson (age 48), CEO, President & Director, per Nexqual as of July 25, 2026 at 22:00 UTC.
| CEO, President & Director | Justice W. Anderson (age 48) |
|---|---|
| CFO & Director | James B. Anderson (age 55) |
| Vice President of Sales - Amerx Health Care Corp. | George Otis Borak (age 64) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ECIA | Encision, Inc. | USD 0.05 | ▲ 0% |
| RBCL | RBC LIFE SCIENCE INC | USD 0 | ▲ 0% |
| QMDT | QUICK-MED TECHNOLOGIES INC | USD 0 | ▲ 0% |
| IEHC | IEH Corp. | USD 23.19 | ▼ 1.32% |
| IVRO | InVitro International | USD 0.06 | ▼ 24.94% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 22:00 UTC. This page is informational and not investment advice.